Neurocrine Biosciences Inc (NAS:NBIX)
$ 142 3.52 (2.54%) Market Cap: 14.29 Bil Enterprise Value: 13.24 Bil PE Ratio: 39.12 PB Ratio: 5.99 GF Score: 89/100

Neurocrine Biosciences Inc at Stifel CNS Day Transcript

Apr 01, 2021 / 04:30PM GMT
Release Date Price: $98.18 (+0.96%)
Paul Andrew Matteis
Stifel, Nicolaus & Company, Incorporated, Research Division - Co-Head of the Biotech Team, MD & Senior Analyst

Great. Thanks very much. It's my pleasure to be hosting a panel that can trend spotlight and talk about different assets within Neurocrine's pipeline with Neurocrine's Chief Medical Officer, Eiry Roberts; and Chief Business Development Officer, Kyle Gano. So thank you both for joining and always enjoy doing the panel with the 2 of you.

I think maybe to start, I don't know, Eiry, if you'd like to make any kind of opening remarks on some of your R&D programs that you're going to have data soon. And feel free to do so, or if not, we can just kind of go 1 by 1 and as you know, I have questions on each. So up to you, but thank you again.

Eiry Wyn Roberts
Neurocrine Biosciences, Inc. - Chief Medical Officer

Yes. Well, thanks very much, Paul. It's great to be here, and hi to everybody. We're delighted to be here. Thanks to Stifel for inviting us today. Just wanted to start really and we can then get straight into

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot